Cogent Biosciences ($COGT) Insider Trading & Smart Money Activity

Cogent Biosciences, Inc. · Biotechnology · Latest filing May 15, 2026

Cogent Biosciences, Inc. ($COGT) has 3 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 3
Analyst ratings on file: 0

COGT insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	1 / 2
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All COGT insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
May 15, 2026	13F	Rtw Investments	Reduced	-2.13M sh	$180.68M	-0.0%	+1.5%	Read
May 15, 2026	13F	Rtw Investments	Reduced	-2.13M sh	$211.25M	-0.0%	+1.5%	Read
May 14, 2026	13F	Exoduspoint Capital Management	New	+372.18K sh	$14.40M	-4.7%	-3.0%	Read

1W / 1M / 6M = how COGT moved from the trade or filing date.

Institutions moving COGT (13F)

Frequently asked questions

Which institutions changed their COGT positions?

Recent 13F filers moving the stock include Rtw Investments and Exoduspoint Capital Management.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text